Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Aryabhatta Sadhu: Effective Hemotherapy Beyond Transfusion
Aryabhatta Sadhu/LinkedIn
May 27, 2026, 15:43

Aryabhatta Sadhu: Effective Hemotherapy Beyond Transfusion

Aryabhatta Sadhu, Attending Consultant and Head of Transfusion Medicine at Fortis Hospital Shalimar Bagh, New Delhi, shared a post on LinkedIn:

”Most hospitals still treat plasma as a ‘bleeding product.’

That is clinically dangerous.

FFP is not volume expansion.

It is not nutritional support.

And it is definitely not a reflex response to abnormal coagulation reports in a non-bleeding patient.

The deeper problem is that many coagulation decisions are still being made through habit rather than haemostatic reasoning.

A mildly deranged INR before a procedure?-‘Give 4 units FFP.’

Massive transfusion with ongoing dilutional coagulopathy? – Plasma delayed until the patient is already spiralling.

Liver disease with chronically elevated INR but preserved haemostasis? – Plasma given to ‘correct numbers.’

This is not evidence-based transfusion medicine.
This is institutional pattern repetition.

The irony is that inappropriate plasma transfusion is not a harmless excess:

  • TRALI risk
  • TACO
  • unnecessary donor exposure
  • inventory strain
  • delayed access for patients with actual factor deficiency states
  • and a false sense of haemostatic correction

Modern transfusion medicine cannot function as a product-dispensing specialty.

It has to evolve into a consultative discipline integrating:

  • clinical haemostasis
  • critical care physiology
  • inventory stewardship
  • and systems-level decision making.

Otherwise we will continue producing blood banks instead of transfusion services.”

Aryabhatta Sadhu: Effective Hemotherapy Beyond Transfusion

Stay updated with Hemostasis Today.

Aryabhatta Sadhu Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Medicine thrombosis
NewsFeed